The aim was to evaluate the expression of NEK2, JMJD4, and REST in tissues of ccRCC and benign kidney to detect the relationship between their expression and clinical, pathological, prognostic, recurrence, and survival findings. The gene discussed is JMJD4; the disease is nonpapillary renal cell carcinoma.